Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Receivables - Other: 2016-2024

  • Zepp Health's Receivables - Other fell 34.86% to $5.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.8 million, marking a year-over-year decrease of 34.86%. This contributed to the annual value of $5.8 million for FY2024, which is 34.86% down from last year.
  • Zepp Health's Receivables - Other amounted to $5.8 million in Q4 2024, which was down 34.86% from $8.9 million recorded in Q4 2023.
  • Over the past 5 years, Zepp Health's Receivables - Other peaked at $131.8 million during Q4 2020, and registered a low of $5.8 million during Q4 2024.
  • For the 3-year period, Zepp Health's Receivables - Other averaged around $11.6 million, with its median value being $8.9 million (2023).
  • Data for Zepp Health's Receivables - Other shows a maximum YoY slumped of 64.81% (in 2021) over the last 5 years.
  • Zepp Health's Receivables - Other (Quarterly) stood at $131.8 million in 2020, then crashed by 64.81% to $46.4 million in 2021, then slumped by 56.68% to $20.1 million in 2022, then plummeted by 55.80% to $8.9 million in 2023, then slumped by 34.86% to $5.8 million in 2024.
  • Its last three reported values are $5.8 million in Q4 2024, $8.9 million for Q4 2023, and $20.1 million during Q4 2022.